Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Outbreak News

    NDAA Amendment Proposes Further Scale Up of PPE and Diagnostic Supplies

    By Global Biodefense StaffJune 30, 2020
    Soldiers with the Delaware Army National Guard’s 262nd Component Repair Company, handle boxes of supplies at a coronavirus testing site on the grounds of the Sussex County VA Community-Based Outpatient Clinic in Georgetown, Delaware, May 6, 2020. Photo by Capt. Brendan Mackie
    Share
    Facebook LinkedIn Reddit Email

    “We need more testing supplies, more testing, and more personal protective equipment for workers on the frontlines of this pandemic.”

    U.S. Senator Tammy Baldwin (D-WI) has introduced an amendment to the National Defense Authorization Act of 2021 (NDAA) to scale up nation-wide production of the testing supplies, personal protective equipment, and medical equipment needed at the local level to address the ongoing COVID-19 pandemic.

    Senator Baldwin’s amendment includes legislation she introduced in April with Senator Chris Murphy (D-CT). The Medical Supply Transparency and Delivery Act requires the president to utilize all available authorities under the Defense Production Act to mobilize a federal response to the pandemic through an equitable and transparent process. Key parts of Baldwin’s legislation are included in the House-passed HEROES Act, but the Republican majority in the Senate has not taken action on the legislation.

    “New coronavirus cases are rising in states across the country, which means we need more testing supplies, more testing, and more personal protective equipment for workers on the frontlines of this pandemic,” said Senator Baldwin.

    The NDAA is being considered on the Senate floor this week.

    The full amendment is available here.

    COVID-19 Editor Pick Frontline Responders Individual Protection Legislative Public Health Emergency Rapid Diagnostics SARS-CoV-2 Supply Chain
    Share. Facebook LinkedIn Reddit Email
    Previous Article4 Unusual Things We’ve Learned About Coronavirus Since the Start of the Pandemic
    Next Article COVID-19 Causes Blood-Clotting Cells to Go Into Overdrive

    Related Stories

    First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

    December 5, 2023

    Chlorine Exposure Biomarkers in a Large Animal Model

    December 5, 2023

    ARPA-H Announces New Tiered Proposal Submission System to Reduce Applicant Barriers

    December 5, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.